SMA Newsroom

We are pleased to share the latest community update from Roche with several topics that are relevant to our SMA Community.

We are pleased to share the latest community update from Roche, announcing that the CHMP (Committee for Medicinal Products for Human Use) at the European Medicines Agency (EMA) has recommended the approval of an indication extension for risdiplam (Evrysdi), for all ages, from birth.

Biocad, a Russian biotechnology company, shares a community statement on its gene therapy product, ANB-004, which is being developed to treat SMA.

We are pleased to share with you the latest community update issued by Biogen.